← Back to Clinical Trials
Recruiting NCT07340385

NCT07340385 Physiological and Biochemical Responses to Blood Flow Restriction Training

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07340385
Status Recruiting
Phase
Sponsor Afyonkarahisar Health Sciences University
Condition Healthy Individuals
Study Type OBSERVATIONAL
Enrollment 30 participants
Start Date 2026-01-20
Primary Completion 2027-01-20

Eligibility & Interventions

Sex Male only
Min Age 18 Years
Max Age 40 Years
Study Type OBSERVATIONAL
Interventions
Blood Flow Restriction Training

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 30 participants in total. It began in 2026-01-20 with a primary completion date of 2027-01-20.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study is designed to examine the short-term and long-term effects of blood flow restriction exercise training on physiological and biochemical markers in individuals who are new to strength training and in experienced athletes training at different load levels. This exercise method involves placing a special inflatable cuff around the upper part of the thigh. The cuff partially limits blood flow to the area, which helps the muscles work more effectively during exercise. The cuff will be applied only to the individual's dominant leg (the leg you use more often in daily activities), but all exercises will be performed using both legs. The exercise program will last for a total of six weeks and will be carried out twice per week. The pressure applied by the cuff will be individually adjusted based on each participant's physical characteristics to ensure safety and comfort. The study will include a total of 30 healthy participants aged between 18 and 40 years. Participants will be divided into two groups: individuals who have recently started strength training and experienced athletes with different levels of training experience.

Eligibility Criteria

Inclusion Criteria: * Voluntary participation of healthy adults * Age between 18 and 40 years * No history of orthopedic pathology or current symptoms affecting the lower extremities * For individuals with prior training experience: engagement in strength training at least two days per week for the past year across different sports disciplines * For individuals new to strength training: no regular participation in strength training within the past six months Exclusion Criteria: * History of hypertension, cardiovascular diseases, peripheral vascular diseases, deep vein thrombosis, neurological disorders, obesity, or a diagnosis of diabetes * Current or previous diagnosis of cancer * Individuals who do not consent to participate in the study

Contact & Investigator

Central Contact

Dilara KARA

✉ dilaradonder@gmail.com

📞 +90 530 237 1991

Frequently Asked Questions

Who can join the NCT07340385 clinical trial?

This trial is open to male participants only, aged 18 Years or older, up to 40 Years, studying Healthy Individuals. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07340385 currently recruiting?

Yes, NCT07340385 is actively recruiting participants. Contact the research team at dilaradonder@gmail.com for enrollment information.

Where is the NCT07340385 trial being conducted?

This trial is being conducted at Afyonkarahisar, Turkey (Türkiye).

Who is sponsoring the NCT07340385 clinical trial?

NCT07340385 is sponsored by Afyonkarahisar Health Sciences University. The trial plans to enroll 30 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology